 |
ferumoxytol |
|---|---|
| Trade Name | |
| Orphan Indication | For use in magnetic resonance imaging to assess, and monitor treatment of solid tumor malignancies previously diagnosed in pediatric patients (age 16 years and younger) |
| USA Market Approval | USA |
| USA Designation Date | 2012-04-06 00:00:00 |
| Sponsor | ArsNova Partners, LLC;38 Frederick Street;Newton, Massachusetts, 02460 |
